We are live on ! Find out more
AGM

Alpine Global Management Portfolio holdings

AUM $668M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-7.35%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$680M
AUM Growth
+$240M
Cap. Flow
+$303M
Cap. Flow %
44.6%
Top 10 Hldgs %
20.02%
Holding
890
New
589
Increased
62
Reduced
40
Closed
122

Sector Composition

Rank Sector Weight
1 Financials 16.96%
2 Healthcare 15.53%
3 Consumer Discretionary 13.62%
4 Technology 13.52%
5 Industrials 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBRX icon
676
ImmunityBio
IBRX
$7.15B
$90K 0.01%
+14,805
New +$111K
SPRU icon
677
Spruce Power Holding Corp
SPRU
$36.6M
$90K 0.01%
+3,384
New +$131K
SOLO
678
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$90K 0.01%
39,296
+9,520
+32% +$30.2K
PRVB
679
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$90K 0.01%
+16,074
New +$102K
AERI
680
DELISTED
Aerie Pharmaceuticals
AERI
$90K 0.01%
+12,831
New +$134K
BBCP icon
681
Concrete Pumping Holdings
BBCP
$491M
$89K 0.01%
+10,887
New +$93.1K
BNGO icon
682
Bionano Genomics
BNGO
$12.5M
$89K 0.01%
+50
New +$134K
OCGN icon
683
Ocugen
OCGN
$403M
$89K 0.01%
+19,646
New +$148K
ZY
684
DELISTED
Zymergen Inc. Common Stock
ZY
$89K 0.01%
+13,301
New +$129K
MCRB icon
685
Seres Therapeutics
MCRB
$45M
$88K 0.01%
+529
New +$84.1K
ENDP
686
DELISTED
Endo International plc
ENDP
$88K 0.01%
+23,500
New +$114K
AEVA
687
Aeva Technologies
AEVA
$956M
$87K 0.01%
+2,294
New +$96.4K
MVST icon
688
Microvast
MVST
$237M
$87K 0.01%
15,416
-454,021
-97% -$3.59M
INO icon
689
Inovio Pharmaceuticals
INO
$85.6M
$86K 0.01%
+1,437
New +$115K
MVIS icon
690
Microvision
MVIS
$84.8M
$86K 0.01%
+17,155
New +$136K
EVLO
691
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$86K 0.01%
+710
New +$120K
CVM icon
692
CEL-SCI Corp
CVM
$19.9M
$83K 0.01%
+392
New +$120K
GBIO
693
DELISTED
Generation Bio
GBIO
$83K 0.01%
+1,175
New +$205K
IVVD icon
694
Invivyd
IVVD
$160M
$83K 0.01%
+11,468
New +$298K
DFTX
695
Definium Therapeutics
DFTX
$5.6B
$82K 0.01%
+3,979
New +$127K
FFAIW
696
DELISTED
Faraday Future Intelligent Electric Warrant
FFAIW
$82K 0.01%
+87,037
New +$128K
SPIR.WS
697
DELISTED
Spire Global, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per whole share
SPIR.WS
$79K 0.01%
181,696
-67,500
-27% -$63.9K
UONEK icon
698
Urban One Class D
UONEK
$22.4M
$74K 0.01%
+2,176
New +$106K
ACTG icon
699
Acacia Research
ACTG
$437M
$68K 0.01%
+13,270
New +$71.6K
BIOTW
700
DELISTED
Biotech Acquisition Company Warrant
BIOTW
$67K 0.01%
+103,502
New +$71.8K

Similar funds

Alpine Global Management's Q4 2021 Portfolio in Review

As of Q4 2021, Alpine Global Management held 890 positions worth $680M, up 54% from $440M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Alpine Global Management deployed $303M of net new capital in Q4 2021, opening 589 new positions and adding to 62 existing holdings. Its largest new stake was iShares Biotechnology ETF: 82,290 shares worth $12.6M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was IHS Markit Ltd. Common Shares, an estimated $20.6M trimmed.

  • Alpine Global Management's largest Q4 2021 buy was iShares Biotechnology ETF: 82,290 shares worth $12.6M.
  • Alpine Global Management added most to Gores Guggenheim, Inc. Class A Common Stock in Q4 2021, an estimated $6.1M increase.
  • Alpine Global Management's biggest Q4 2021 reduction was IHS Markit Ltd. Common Shares, cutting an estimated $20.6M.
  • Alpine Global Management fully exited Mirion Technologies in Q4 2021, selling an estimated $20.4M.
  • Alpine Global Management's ten largest holdings make up 20% of its $680M portfolio in Q4 2021.
  • Alpine Global Management opened 589 new positions and closed 122 in Q4 2021.
  • Alpine Global Management's portfolio value rose 54% quarter-over-quarter to $680M.

Based on Alpine Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.